The global lohexol API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global lohexol API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global lohexol API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global lohexol API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global lohexol API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global lohexol API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for lohexol API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global lohexol API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare AS, Hovione FarmaCiencia SA, Interpharma Praha AS, JUSTE GROUP, LGM PHARMA, Adooq, 顿颈惫颈鈥檚, MedChemExpress, STELLENCE PHARMSCIENCE LIMITED, Hichi Pharmaceutical Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
lohexol API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
笔耻谤颈迟测鈮�98%
Purity<98%
麻豆原创 segment by Application
Injection
Others
Major players covered
GE Healthcare AS
Hovione FarmaCiencia SA
Interpharma Praha AS
JUSTE GROUP
LGM PHARMA
Adooq
顿颈惫颈鈥檚
MedChemExpress
STELLENCE PHARMSCIENCE LIMITED
Hichi Pharmaceutical Corporation
Beilu Pharma
Starry Pharmaceutical
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe lohexol API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of lohexol API, with price, sales quantity, revenue, and global market share of lohexol API from 2020 to 2025.
Chapter 3, the lohexol API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the lohexol API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and lohexol API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of lohexol API.
Chapter 14 and 15, to describe lohexol API sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global lohexol API Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 笔耻谤颈迟测鈮�98%
1.3.3 Purity<98%
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global lohexol API Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Injection
1.4.3 Others
1.5 Global lohexol API 麻豆原创 Size & Forecast
1.5.1 Global lohexol API Consumption Value (2020 & 2024 & 2031)
1.5.2 Global lohexol API Sales Quantity (2020-2031)
1.5.3 Global lohexol API Average Price (2020-2031)
2 Manufacturers Profiles
2.1 GE Healthcare AS
2.1.1 GE Healthcare AS Details
2.1.2 GE Healthcare AS Major Business
2.1.3 GE Healthcare AS lohexol API Product and Services
2.1.4 GE Healthcare AS lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 GE Healthcare AS Recent Developments/Updates
2.2 Hovione FarmaCiencia SA
2.2.1 Hovione FarmaCiencia SA Details
2.2.2 Hovione FarmaCiencia SA Major Business
2.2.3 Hovione FarmaCiencia SA lohexol API Product and Services
2.2.4 Hovione FarmaCiencia SA lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Hovione FarmaCiencia SA Recent Developments/Updates
2.3 Interpharma Praha AS
2.3.1 Interpharma Praha AS Details
2.3.2 Interpharma Praha AS Major Business
2.3.3 Interpharma Praha AS lohexol API Product and Services
2.3.4 Interpharma Praha AS lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Interpharma Praha AS Recent Developments/Updates
2.4 JUSTE GROUP
2.4.1 JUSTE GROUP Details
2.4.2 JUSTE GROUP Major Business
2.4.3 JUSTE GROUP lohexol API Product and Services
2.4.4 JUSTE GROUP lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 JUSTE GROUP Recent Developments/Updates
2.5 LGM PHARMA
2.5.1 LGM PHARMA Details
2.5.2 LGM PHARMA Major Business
2.5.3 LGM PHARMA lohexol API Product and Services
2.5.4 LGM PHARMA lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 LGM PHARMA Recent Developments/Updates
2.6 Adooq
2.6.1 Adooq Details
2.6.2 Adooq Major Business
2.6.3 Adooq lohexol API Product and Services
2.6.4 Adooq lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Adooq Recent Developments/Updates
2.7 顿颈惫颈鈥檚
2.7.1 顿颈惫颈鈥檚 Details
2.7.2 顿颈惫颈鈥檚 Major Business
2.7.3 顿颈惫颈鈥檚 lohexol API Product and Services
2.7.4 顿颈惫颈鈥檚 lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 顿颈惫颈鈥檚 Recent Developments/Updates
2.8 MedChemExpress
2.8.1 MedChemExpress Details
2.8.2 MedChemExpress Major Business
2.8.3 MedChemExpress lohexol API Product and Services
2.8.4 MedChemExpress lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 MedChemExpress Recent Developments/Updates
2.9 STELLENCE PHARMSCIENCE LIMITED
2.9.1 STELLENCE PHARMSCIENCE LIMITED Details
2.9.2 STELLENCE PHARMSCIENCE LIMITED Major Business
2.9.3 STELLENCE PHARMSCIENCE LIMITED lohexol API Product and Services
2.9.4 STELLENCE PHARMSCIENCE LIMITED lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 STELLENCE PHARMSCIENCE LIMITED Recent Developments/Updates
2.10 Hichi Pharmaceutical Corporation
2.10.1 Hichi Pharmaceutical Corporation Details
2.10.2 Hichi Pharmaceutical Corporation Major Business
2.10.3 Hichi Pharmaceutical Corporation lohexol API Product and Services
2.10.4 Hichi Pharmaceutical Corporation lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Hichi Pharmaceutical Corporation Recent Developments/Updates
2.11 Beilu Pharma
2.11.1 Beilu Pharma Details
2.11.2 Beilu Pharma Major Business
2.11.3 Beilu Pharma lohexol API Product and Services
2.11.4 Beilu Pharma lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Beilu Pharma Recent Developments/Updates
2.12 Starry Pharmaceutical
2.12.1 Starry Pharmaceutical Details
2.12.2 Starry Pharmaceutical Major Business
2.12.3 Starry Pharmaceutical lohexol API Product and Services
2.12.4 Starry Pharmaceutical lohexol API Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Starry Pharmaceutical Recent Developments/Updates
3 Competitive Environment: lohexol API by Manufacturer
3.1 Global lohexol API Sales Quantity by Manufacturer (2020-2025)
3.2 Global lohexol API Revenue by Manufacturer (2020-2025)
3.3 Global lohexol API Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of lohexol API by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 lohexol API Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 lohexol API Manufacturer 麻豆原创 Share in 2024
3.5 lohexol API 麻豆原创: Overall Company Footprint Analysis
3.5.1 lohexol API 麻豆原创: Region Footprint
3.5.2 lohexol API 麻豆原创: Company Product Type Footprint
3.5.3 lohexol API 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global lohexol API 麻豆原创 Size by Region
4.1.1 Global lohexol API Sales Quantity by Region (2020-2031)
4.1.2 Global lohexol API Consumption Value by Region (2020-2031)
4.1.3 Global lohexol API Average Price by Region (2020-2031)
4.2 North America lohexol API Consumption Value (2020-2031)
4.3 Europe lohexol API Consumption Value (2020-2031)
4.4 Asia-Pacific lohexol API Consumption Value (2020-2031)
4.5 South America lohexol API Consumption Value (2020-2031)
4.6 Middle East & Africa lohexol API Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global lohexol API Sales Quantity by Type (2020-2031)
5.2 Global lohexol API Consumption Value by Type (2020-2031)
5.3 Global lohexol API Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global lohexol API Sales Quantity by Application (2020-2031)
6.2 Global lohexol API Consumption Value by Application (2020-2031)
6.3 Global lohexol API Average Price by Application (2020-2031)
7 North America
7.1 North America lohexol API Sales Quantity by Type (2020-2031)
7.2 North America lohexol API Sales Quantity by Application (2020-2031)
7.3 North America lohexol API 麻豆原创 Size by Country
7.3.1 North America lohexol API Sales Quantity by Country (2020-2031)
7.3.2 North America lohexol API Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe lohexol API Sales Quantity by Type (2020-2031)
8.2 Europe lohexol API Sales Quantity by Application (2020-2031)
8.3 Europe lohexol API 麻豆原创 Size by Country
8.3.1 Europe lohexol API Sales Quantity by Country (2020-2031)
8.3.2 Europe lohexol API Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific lohexol API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific lohexol API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific lohexol API 麻豆原创 Size by Region
9.3.1 Asia-Pacific lohexol API Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific lohexol API Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America lohexol API Sales Quantity by Type (2020-2031)
10.2 South America lohexol API Sales Quantity by Application (2020-2031)
10.3 South America lohexol API 麻豆原创 Size by Country
10.3.1 South America lohexol API Sales Quantity by Country (2020-2031)
10.3.2 South America lohexol API Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa lohexol API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa lohexol API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa lohexol API 麻豆原创 Size by Country
11.3.1 Middle East & Africa lohexol API Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa lohexol API Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 lohexol API 麻豆原创 Drivers
12.2 lohexol API 麻豆原创 Restraints
12.3 lohexol API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of lohexol API and Key Manufacturers
13.2 Manufacturing Costs Percentage of lohexol API
13.3 lohexol API Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 lohexol API Typical Distributors
14.3 lohexol API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
GE Healthcare AS
Hovione FarmaCiencia SA
Interpharma Praha AS
JUSTE GROUP
LGM PHARMA
Adooq
顿颈惫颈鈥檚
MedChemExpress
STELLENCE PHARMSCIENCE LIMITED
Hichi Pharmaceutical Corporation
Beilu Pharma
Starry Pharmaceutical
听
听
*If Applicable.
